SEARCH

SEARCH BY CITATION

References

  • 1
    Ahmed A, Forrest EH. Commentary: physical activity and NAFLD – cause or effect? Aliment Pharmacol Ther 2012; 36: 10978.
  • 2
    Gerber L, Otgonsuren M, Mishra A, et al. Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Aliment Pharmacol Ther 2012; 36: 77281.
  • 3
    Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology 2006; 6: 30.
  • 4
    Anzuini F, Battistella A, Izotti A, et al. Physical activity and cancer prevention: a review of current evidence and biomechanisms. J Prev Med Hygiene 2011; 52: 17480.
  • 5
    Irwin ML, McTiernan A, Manson J. Physical activity and survival in post-menopausal women with breast cancer: results from the women's health initiative. Cancer Prev Res (Phila) 2011; 4: 5229.
  • 6
    Franco OH, deLaet C, Peeters A, et al. Effects of physical activity on life expectancy in cardiovascular disease. Arch Intern Med 2005; 165: 235566.
  • 7
    Fogelholm M, Kukkonen-Hayula K. Does physical activity prevent weight gain. Obes Rev 2000; 1: 95111.
  • 8
    Wing RR. Physical Activity in the treatment of the adulthood overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 1999; 31: 554752.
  • 9
    Catenacci VA, Wyatt HR. The role of physical activity in producing and maintaining weight loss. Nat Clin Pract Endocrinol Metab 2007; 7: 51829.
  • 10
    Warburton DE, Katzmarzyk PT, Rhodes RE, et al. Evidence-informed physical activity guidelines for Canadian adults. Can J Public Health 2007; 98(Suppl. 2): S1668.
  • 11
    Lira FS, Carnevali LC, Zanchi NE, et al. Exervcise intensity modification of hepatic lipid metabolism. J Nutr & Metab 2012; 2012: 809576.
  • 12
    Hansen D, Dendale P, Jonkers RAM, et al. Continuous low-to-moderate intensity exercise training is as effective as moderate-to-high exercise intensity training at lowering HbA1c in obese Type 2 diabetes patients. Diabetologia 2009; 52: 178997.